Myron M Levine Selected Research

Flagellin

1/2017	Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
5/2014	An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.
10/2011	Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myron M Levine Research Topics

Disease

43	Infections 01/2023 - 03/2003
30	Typhoid Fever (Typhoid) 12/2023 - 01/2003
23	Diarrhea 12/2021 - 04/2002
13	Measles 01/2022 - 05/2003
10	Cholera 01/2023 - 11/2012
9	Bacillary Dysentery (Shigellosis) 01/2021 - 01/2003
8	Fever (Fevers) 01/2019 - 04/2002
7	Gastroenteritis 01/2021 - 08/2010
7	Salmonella Infections (Salmonellosis) 11/2018 - 04/2012
6	Bacteremia 01/2017 - 02/2009
5	Inflammation (Inflammations) 01/2021 - 05/2008
4	Ebola Hemorrhagic Fever 12/2019 - 02/2015
4	Communicable Diseases (Infectious Diseases) 01/2012 - 03/2007
3	Vesicular Stomatitis 01/2017 - 08/2015
3	Tetanus 01/2016 - 03/2004
3	Pneumococcal Infections 05/2006 - 12/2002
2	Acute Disease 01/2024 - 01/2016
2	Pneumonia (Pneumonitis) 12/2021 - 01/2018
2	Poliomyelitis (Polio) 01/2021 - 03/2004
2	Dysentery 01/2021 - 05/2016
2	Human Influenza (Influenza) 01/2017 - 01/2016
2	Paratyphoid Fever 01/2017 - 07/2007
2	Vaccinia 04/2016 - 01/2016
2	Pain (Aches) 01/2016 - 01/2016
2	Tularemia 08/2015 - 04/2009
2	Sepsis (Septicemia) 05/2014 - 12/2009
2	Gastritis 05/2014 - 01/2014
2	Diphtheria 09/2006 - 03/2004
2	Whooping Cough (Pertussis) 09/2006 - 03/2004
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Coinfection 01/2021
1	Cryptosporidiosis 01/2019
1	Malaria 01/2019
1	Giardiasis 01/2019
1	Achlorhydria (Hypochlorhydria) 01/2017
1	Gallbladder Neoplasms (Gallbladder Cancer) 11/2016

Drug/Important Bio-Agent (IBA)

79	VaccinesIBA 01/2023 - 04/2002
17	AntibodiesIBA 01/2023 - 05/2003
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 06/2005
11	AntigensIBA 01/2023 - 01/2003
9	Polysaccharides (Glycans)IBA 07/2018 - 08/2004
7	Conjugate VaccinesIBA 12/2023 - 12/2002
7	cholera vaccine CVD 103-HgRIBA 01/2023 - 01/2014
7	Immunoglobulin G (IgG)IBA 01/2021 - 08/2004
6	Cholera Vaccines FDA Link 01/2023 - 05/2006
6	DNA VaccinesIBA 03/2009 - 01/2003
5	Attenuated VaccinesIBA 01/2023 - 12/2013
5	Lysergic Acid Diethylamide (LSD)IBA 01/2021 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2005
5	Measles VaccineIBA 07/2011 - 07/2005
4	Neutralizing AntibodiesIBA 01/2021 - 05/2003
4	Drinking WaterIBA 11/2020 - 07/2017
4	O Antigens (O Antigen)IBA 11/2019 - 08/2004
4	EnzymesIBA 05/2014 - 07/2005
4	SolutionsIBA 05/2014 - 07/2013
3	CytokinesIBA 01/2022 - 03/2009
3	Immunoglobulin A (IgA)IBA 11/2019 - 01/2017
3	Immunoglobulin M (IgM)IBA 11/2019 - 07/2011
3	Cholera ToxinIBA 11/2019 - 01/2017
3	Enterotoxins (Enterotoxin)IBA 01/2019 - 02/2012
3	GlycoconjugatesIBA 07/2018 - 04/2012
3	FlagellinIBA 01/2017 - 10/2011
3	Glycoproteins (Glycoprotein)IBA 04/2016 - 05/2006
3	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2016 - 03/2003
3	ImmunosorbentsIBA 05/2014 - 07/2005
3	Rotavirus VaccinesIBA 04/2012 - 08/2010
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	PepsinogensIBA 01/2021 - 10/2020
2	Tetanus Antitoxin FDA Link 01/2021 - 09/2006
2	Blood Group Antigens (Blood Groups)IBA 11/2019 - 01/2017
2	LipopolysaccharidesIBA 11/2018 - 05/2014
2	Capsules (Microcapsules)IBA 07/2018 - 04/2012
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 01/2016
2	Bacterial VaccinesIBA 01/2017 - 02/2009
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2017 - 08/2015
2	Combined VaccinesIBA 06/2015 - 03/2004
2	16S Ribosomal RNAIBA 02/2015 - 06/2014
2	Pepsinogen A (Pepsinogen)IBA 05/2014 - 01/2014
2	ZincIBA 07/2013 - 07/2013
2	Secretory Immunoglobulin A (SIgA)IBA 03/2011 - 11/2008
2	Hemagglutinins (Hemagglutinin)IBA 05/2006 - 08/2005
1	TCVSIBA 12/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Nucleic AcidsIBA 01/2022
1	Immune Sera (Antisera)IBA 01/2021
1	NucleotidesIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	A 17 (A-17)IBA 11/2020
1	Monoclonal AntibodiesIBA 12/2019
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2019
1	heat stable toxin (E coli)IBA 01/2019
1	Malaria VaccinesIBA 01/2019
1	tartrate-sensitive acid phosphataseIBA 11/2018
1	EpitopesIBA 07/2018
1	SandIBA 01/2018

Therapy/Procedure

5	Fluid Therapy (Oral Rehydration Therapy) 05/2016 - 04/2008
2	Therapeutics 12/2019 - 05/2014
2	Traction 01/2017 - 01/2012
1	Treatment Delay 01/2018